Thermo Fisher Scientific announced an R&D partnership with AstraZeneca BioVentureHub. Crinetics received FDA approval of Palsonify (paltusotine) to treat acromegaly in adults. The agency approved ...
The Trump administration is pursuing deals across up to 30 industries. Read more at straitstimes.com. Read more at ...
Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...
Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early ...
The US FDA has accepted the supplemental biologics license application (sBLA) for trastuzumab deruxtecan (T-DXd; Enhertu) followed by paclitaxel (Taxol), trastuzumab (Herceptin), and pertuzumab ...
By Charlie Conchie LONDON (Reuters) -AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from ...
Zacks Investment Research on MSN
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...
New data centers and service centers designed to enhance infrastructure coverage and stay ahead of global growing demand for ...
AstraZeneca saw its share prices jump to a new all-time high on Wednesday, as investors cheered reports that President Donald ...
Ten stocks finished the trading session with hefty gains, mirroring a broader market optimism following President Donald ...
The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback